Works by Huland, Hartwig


Results: 147
    1

    Health-insurance status is a determinant of the stage at presentation and of cancer control in European men treated with radical prostatectomy for clinically localized prostate cancer.

    Published in:
    BJU International, 2007, v. 99, n. 6, p. 1404, doi. 10.1111/j.1464-410X.2007.06771.x
    By:
    • Gallina, Andrea;
    • Karakiewicz, Pierre I.;
    • Chun, Felix K.-H.;
    • Briganti, Alberto;
    • Graefen, Markus;
    • Montorsi, Francesco;
    • Walz, Jochen;
    • Jeldres, Claudio;
    • Erbersdobler, Andreas;
    • Salonia, Andrea;
    • Suardi, Nazareno;
    • Deh, Federico;
    • Schlomm, Thorsten;
    • Scattoni, Vincenzo;
    • Haese, Alexander;
    • Heinzer, Hans;
    • Valiquette, Luc;
    • Rigatti, Patrizio;
    • Huland, Hartwig
    Publication type:
    Article
    2
    3

    Surgical volume is related to the rate of positive surgical margins at radical prostatectomy in European patients.

    Published in:
    BJU International, 2006, v. 98, n. 6, p. 1204, doi. 10.1111/j.1464-410X.2006.06442.x
    By:
    • Chun, Felix K.-H.;
    • Briganti, Alberto;
    • Antebi, Elie;
    • Graefen, Markus;
    • Currlin, Eike;
    • Steuber, Thomas;
    • Schlomm, Thorsten;
    • Walz, Jochen;
    • Haese, Alexander;
    • Friedrich, Martin G.;
    • Ahyai, Sascha A.;
    • Eichelberg, Christian;
    • Salomon, Georg;
    • Gallina, Andrea;
    • Erbersdobler, Andreas;
    • Perrotte, Paul;
    • Heinzer, Hans;
    • Huland, Hartwig;
    • Karakiewicz, Pierre I.
    Publication type:
    Article
    4
    5

    Significant upgrading affects a third of men diagnosed with prostate cancer: predictive nomogram and internal validation.

    Published in:
    BJU International, 2006, v. 98, n. 2, p. 329, doi. 10.1111/j.1464-410X.2006.06262.x
    By:
    • Chun, Felix K.-H.;
    • Briganti, Alberto;
    • Shariat, Shahrokh F.;
    • Graefen, Markus;
    • Montorsi, Francesco;
    • Erbersdobler, Andreas;
    • Steuber, Thomas;
    • Salonia, Andrea;
    • Currlin, Eike;
    • Scattoni, Vincenzo;
    • Friedrich, Martin G.;
    • Schlomm, Thorsten;
    • Haese, Alexander;
    • Michl, Uwe;
    • Colombo, Renzo;
    • Heinzer, Hans;
    • Valiquette, Luc;
    • Rigatti, Patrizio;
    • Roehrborn, Claus G.;
    • Huland, Hartwig
    Publication type:
    Article
    6

    Institutional variability in the accuracy of urinary cytology for predicting recurrence of transitional cell carcinoma of the bladder.

    Published in:
    BJU International, 2006, v. 97, n. 5, p. 997, doi. 10.1111/j.1464-410X.2006.06036.x
    By:
    • Karakiewicz, Pierre I.;
    • Benayoun, Serge;
    • Zippe, Craig;
    • Lüdecke, Gerson;
    • Boman, Hans;
    • Sanchez-Carbayo, Marta;
    • Casella, Roberto;
    • Mian, Christine;
    • Friedrich, Martin G.;
    • Eissa, Sanaa;
    • Akaza, Hideyuki;
    • Huland, Hartwig;
    • Hedelin, Hans;
    • Rupesh, Raina;
    • Miyanaga, Naoto;
    • Sagalowsky, Arthur I.;
    • Marberger, Michael J.;
    • Shariat, Shahrokh F.
    Publication type:
    Article
    7
    8
    9
    10

    Expression of CCCTC‐binding factor (CTCF) is linked to poor prognosis in prostate cancer.

    Published in:
    Molecular Oncology, 2020, v. 14, n. 1, p. 129, doi. 10.1002/1878-0261.12597
    By:
    • Höflmayer, Doris;
    • Steinhoff, Amélie;
    • Hube‐Magg, Claudia;
    • Kluth, Martina;
    • Simon, Ronald;
    • Burandt, Eike;
    • Tsourlakis, Maria Christina;
    • Minner, Sarah;
    • Sauter, Guido;
    • Büscheck, Franziska;
    • Wilczak, Waldemar;
    • Steurer, Stefan;
    • Huland, Hartwig;
    • Graefen, Markus;
    • Haese, Alexander;
    • Heinzer, Hans;
    • Schlomm, Thorsten;
    • Jacobsen, Frank;
    • Hinsch, Andrea;
    • Poos, Alexandra M.
    Publication type:
    Article
    11
    12
    13

    High BCAR1 expression is associated with early PSA recurrence in ERG negative prostate cancer.

    Published in:
    2018
    By:
    • Heumann, Asmus;
    • Heinemann, Nina;
    • Hube-Magg, Claudia;
    • Lang, Dagmar S.;
    • Grupp, Katharina;
    • Kluth, Martina;
    • Minner, Sarah;
    • Möller-Koop, Christina;
    • Graefen, Markus;
    • Heinzer, Hans;
    • Tsourlakis, Maria Christina;
    • Wilczak, Waldemar;
    • Wittmer, Corinna;
    • Jacobsen, Frank;
    • Huland, Hartwig;
    • Simon, Ronald;
    • Schlomm, Thorsten;
    • Sauter, Guido;
    • Steurer, Stefan;
    • Lebok, Patrick
    Publication type:
    journal article
    14
    15
    16
    17
    18
    19

    Upregulation of the heterogeneous nuclear ribonucleoprotein hnRNPA1 is an independent predictor of early biochemical recurrence in TMPRSS2:ERG fusion-negative prostate cancers.

    Published in:
    Virchows Archiv: European Journal of Pathology, 2020, v. 477, n. 5, p. 625, doi. 10.1007/s00428-020-02834-4
    By:
    • Möller, Katharina;
    • Wecker, Anna Lena;
    • Höflmayer, Doris;
    • Fraune, Christoph;
    • Makrypidi-Fraune, Georgia;
    • Hube-Magg, Claudia;
    • Kluth, Martina;
    • Steurer, Stefan;
    • Clauditz, Till S.;
    • Wilczak, Waldemar;
    • Simon, Ronald;
    • Sauter, Guido;
    • Huland, Hartwig;
    • Heinzer, Hans;
    • Haese, Alexander;
    • Schlomm, Thorsten;
    • Weidemann, Sören;
    • Luebke, Andreas M.;
    • Minner, Sarah;
    • Bernreuther, Christian
    Publication type:
    Article
    20
    21
    22
    23

    High-Level γ-Glutamyl-Hydrolase (GGH) Expression is Linked to Poor Prognosis in ERG Negative Prostate Cancer.

    Published in:
    International Journal of Molecular Sciences, 2017, v. 18, n. 2, p. 286, doi. 10.3390/ijms18020286
    By:
    • Melling, Nathaniel;
    • Rashed, Masoud;
    • Schroeder, Cornelia;
    • Hube-Magg, Claudia;
    • Kluth, Martina;
    • Lang, Dagmar;
    • Simon, Ronald;
    • Möller-Koop, Christina;
    • Steurer, Stefan;
    • Sauter, Guido;
    • Jacobsen, Frank;
    • Büscheck, Franziska;
    • Wittmer, Corinna;
    • Clauditz, Till;
    • Krech, Till;
    • Tsourlakis, Maria Christina;
    • Minner, Sarah;
    • Huland, Hartwig;
    • Graefen, Markus;
    • Budäus, Lars
    Publication type:
    Article
    24

    VEGFR-1 Overexpression Identifies a Small Subgroup of Aggressive Prostate Cancers in Patients Treated by Prostatectomy.

    Published in:
    International Journal of Molecular Sciences, 2015, v. 16, n. 4, p. 8591, doi. 10.3390/ijms16048591
    By:
    • Tsourlakis, Maria Christina;
    • Khosrawi, Puya;
    • Weigand, Philipp;
    • Kluth, Martina;
    • Hube-Magg, Claudia;
    • Minner, Sarah;
    • Koop, Christina;
    • Graefen, Markus;
    • Heinzer, Hans;
    • Wittmer, Corinna;
    • Sauter, Guido;
    • Krech, Till;
    • Wilczak, Waldemar Wilczak;
    • Huland, Hartwig;
    • Simon, Ronald;
    • Schlomm, Thorsten;
    • Steurer, Stefan
    Publication type:
    Article
    25

    Secreted Frizzled-Related Protein 4 (SFRP4) Is an Independent Prognostic Marker in Prostate Cancers Lacking TMPRSS2: ERG Fusions.

    Published in:
    Pathology & Oncology Research, 2020, v. 26, n. 4, p. 2709, doi. 10.1007/s12253-020-00861-9
    By:
    • Bernreuther, Christian;
    • Daghigh, Ferdous;
    • Möller, Katharina;
    • Hube-Magg, Claudia;
    • Lennartz, Maximilian;
    • Lutz, Florian;
    • Rico, Sebastian Dwertmann;
    • Fraune, Christoph;
    • Dum, David;
    • Luebke, Andreas M.;
    • Eichenauer, Till;
    • Möller-Koop, Christina;
    • Schlomm, Thorsten;
    • Wittmer, Corinna;
    • Huland, Hartwig;
    • Heinzer, Hans;
    • Graefen, Markus;
    • Haese, Alexander;
    • Burandt, Eike;
    • Tsourlakis, Maria Christina
    Publication type:
    Article
    26
    27
    28
    29
    30

    Increased Cytoplasmic CD138 Expression Is Associated with Aggressive Characteristics in Prostate Cancer and Is an Independent Predictor for Biochemical Recurrence.

    Published in:
    BioMed Research International, 2020, p. 1, doi. 10.1155/2020/5845374
    By:
    • Kind, Simon;
    • Kluth, Martina;
    • Hube-Magg, Claudia;
    • Möller, Katharina;
    • Makrypidi-Fraune, Georgia;
    • Lutz, Florian;
    • Lennartz, Maximilian;
    • Rico, Sebastian Dwertmann;
    • Schlomm, Thorsten;
    • Heinzer, Hans;
    • Höflmayer, Doris;
    • Weidemann, Sören;
    • Uhlig, Ria;
    • Huland, Hartwig;
    • Graefen, Markus;
    • Bernreuther, Christian;
    • Tsourlakis, Maria Christina;
    • Minner, Sarah;
    • Dum, David;
    • Hinsch, Andrea
    Publication type:
    Article
    31
    32
    33
    34
    35
    36

    SNW1 is a prognostic biomarker in prostate cancer.

    Published in:
    Diagnostic Pathology, 2019, v. 14, n. 1, p. N.PAG, doi. 10.1186/s13000-019-0810-8
    By:
    • Höflmayer, Doris;
    • Willich, Carla;
    • Hube-Magg, Claudia;
    • Simon, Ronald;
    • Lang, Dagmar;
    • Neubauer, Emily;
    • Jacobsen, Frank;
    • Hinsch, Andrea;
    • Luebke, Andreas M.;
    • Tsourlakis, Marie Christina;
    • Huland, Hartwig;
    • Graefen, Markus;
    • Haese, Alexander;
    • Heinzer, Hans;
    • Minner, Sarah;
    • Büscheck, Franziska;
    • Sauter, Guido;
    • Schlomm, Thorsten;
    • Steurer, Stefan;
    • Clauditz, Till S.
    Publication type:
    Article
    37

    High mitochondria content is associated with prostate cancer disease progression.

    Published in:
    Molecular Cancer, 2013, v. 12, n. 1, p. 1, doi. 10.1186/1476-4598-12-145
    By:
    • Grupp, Katharina;
    • Jedrzejewska, Karolina;
    • Tsourlakis, Maria Christina;
    • Koop, Christina;
    • Wilczak, Waldemar;
    • Adam, Meike;
    • Quaas, Alexander;
    • Sauter, Guido;
    • Simon, Ronald;
    • Izbicki, Jakob Robert;
    • Graefen, Markus;
    • Huland, Hartwig;
    • Schlomm, Thorsten;
    • Minner, Sarah;
    • Steurer, Stefan
    Publication type:
    Article
    38

    Reduced KLK2 expression is a strong and independent predictor of poor prognosis in ERG‐negative prostate cancer.

    Published in:
    Prostate, 2020, v. 80, n. 13, p. 1097, doi. 10.1002/pros.24038
    By:
    • Bonk, Sarah;
    • Kluth, Martina;
    • Jansen, Kristina;
    • Hube‐Magg, Claudia;
    • Makrypidi‐Fraune, Georgia;
    • Höflmayer, Doris;
    • Weidemann, Sören;
    • Möller, Katharina;
    • Uhlig, Ria;
    • Büscheck, Franziska;
    • Luebke, Andreas M.;
    • Burandt, Eike;
    • Clauditz, Till S.;
    • Steurer, Stefan;
    • Schlomm, Thorsten;
    • Huland, Hartwig;
    • Heinzer, Hans;
    • Sauter, Guido;
    • Simon, Ronald;
    • Dum, David
    Publication type:
    Article
    39
    40

    Loss of CCAAT‐enhancer‐binding protein alpha (CEBPA) is linked to poor prognosis in PTEN deleted and TMPRSS2:ERG fusion type prostate cancers.

    Published in:
    Prostate, 2019, v. 79, n. 3, p. 302, doi. 10.1002/pros.23736
    By:
    • Minner, Sarah;
    • Lutz, Jannes;
    • Hube‐Magg, Claudia;
    • Kluth, Martina;
    • Simon, Ronald;
    • Höflmayer, Doris;
    • Burandt, Eike;
    • Tsourlakis, Maria Christina;
    • Sauter, Guido;
    • Büscheck, Franziska;
    • Wilczak, Waldemar;
    • Steurer, Stefan;
    • Schlomm, Thorsten;
    • Huland, Hartwig;
    • Graefen, Markus;
    • Haese, Alexander;
    • Heinzer, Hans;
    • Jacobsen, Frank;
    • Hinsch, Andrea;
    • Poos, Alexandra
    Publication type:
    Article
    41
    42
    43
    44
    45

    North American Population-Based Validation of the National Comprehensive Cancer Network Practice Guideline Recommendation of Pelvic Lymphadenectomy in Contemporary Prostate Cancer.

    Published in:
    Prostate, 2017, v. 77, n. 5, p. 542, doi. 10.1002/pros.23292
    By:
    • Leyh‐Bannurah, Sami‐Ramzi;
    • Budäus, Lars;
    • Pompe, Raisa;
    • Zaffuto, Emanuele;
    • Briganti, Alberto;
    • Abdollah, Firas;
    • Montorsi, Francesco;
    • Schiffmann, Jonas;
    • Menon, Mani;
    • Shariat, Shahrokh F.;
    • Fisch, Margit;
    • Chun, Felix;
    • Huland, Hartwig;
    • Graefen, Markus;
    • Karakiewicz, Pierre I.
    Publication type:
    Article
    46

    Cytoplasmic accumulation of ELAVL1 is an independent predictor of biochemical recurrence associated with genomic instability in prostate cancer.

    Published in:
    Prostate, 2016, v. 76, n. 3, p. 259, doi. 10.1002/pros.23120
    By:
    • Melling, Nathaniel;
    • Taskin, Berivan;
    • Hube‐Magg, Claudia;
    • Kluth, Martina;
    • Minner, Sarah;
    • Koop, Christina;
    • Grob, Tobias;
    • Graefen, Markus;
    • Heinzer, Hans;
    • Tsourlakis, Maria Christina;
    • Izbicki, Jakob;
    • Wittmer, Corinna;
    • Huland, Hartwig;
    • Simon, Ronald;
    • Wilczak, Waldemar;
    • Sauter, Guido;
    • Steurer, Stefan;
    • Schlomm, Thorsten;
    • Krech, Till
    Publication type:
    Article
    47
    48
    49

    NY-ESO-1 expression is tightly linked to TMPRSS2-ERG fusion in prostate cancer.

    Published in:
    Prostate, 2014, v. 74, n. 10, p. 1012, doi. 10.1002/pros.22816
    By:
    • Grupp, Katharina;
    • Ospina‐Klinck, Daniel;
    • Tsourlakis, Maria Christina;
    • Koop, Christina;
    • Wilczak, Waldemar;
    • Adam, Meike;
    • Simon, Ronald;
    • Sauter, Guido;
    • Izbicki, Jakob Robert;
    • Graefen, Markus;
    • Huland, Hartwig;
    • Steurer, Stefan;
    • Schlomm, Thorsten;
    • Minner, Sarah;
    • Quaas, Alexander
    Publication type:
    Article
    50